Mind Body Intervention for Long COVID-19
This study is testing if a Mind Body Intervention can help people with Long COVID (Post-Acute Sequelae of COVID-19 or COVID Long-Haul). The intervention includes regular educational sessions and lectures, plus reading materials. Individualized sessions are also offered. To join, you must be between 18 and 65 years old, have had a confirmed COVID-19 infection, and have symptoms that are only from COVID-19, not other health issues. You also need a somatic symptom score of 10 or higher on a specific questionnaire (SSS-8). The study aims to see if this intervention reduces your physical symptoms. This study is currently unclear about its recruitment status and plans to enroll 180 participants.
- Study design
- This is an interventional, randomized study comparing a mind-body intervention to usual care and a second mind-body intervention. It plans to enroll 180 participants.
- What's involved
- Participants will engage in regular 1 to 2 hour educational sessions and lectures, and receive supplemental reading material. Individualized sessions will also be offered weekly.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your somatic symptoms will be measured at the beginning of the study, and then at 4 weeks, 8 weeks, and 13 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Mind Body Intervention for Long COVID-19
At a glance
Conditions
NCT06045338
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Beth Israel Deaconess Medical Center
Boston, Massachusettsstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Michael Donnino, MD · PRINCIPAL_INVESTIGATOR · Beth Israel Deaconess Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Somatic Symptom Score-8 (SSS-8)Baseline, 4 weeks, 8 weeks, 13 weeks
Survey questions pertain to pain, the gastrointestinal system, fatigue, dizziness, and cardiovascular complaints. Range of 0-32, with higher scores indicating higher levels of discomfort.